BioSenic S.A.
BIOS.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | €0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | -100% | 1,413.5% | – |
| Gross Profit | €0 | -€0 | €0 | -€0 |
| % Margin | – | – | 100% | -49.4% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | – | – | -13.4% | -1,683.1% |
| Net Income | -€0 | -€0 | €0 | -€0 |
| % Margin | – | – | 18.4% | -4,457.9% |
| EPS Diluted | -0.001 | -0.016 | 0.25 | -0.053 |
| % Growth | 93.2% | -106.5% | 571.7% | – |
| Operating Cash Flow | – | -€0 | -€0 | -€0 |
| Capital Expenditures | – | €0 | €0 | €0 |
| Free Cash Flow | – | €0 | -€0 | -€0 |